Franz X. Vollenweider

Cituota

	Visi	Nuo 2020
Šaltiniai	25366	11896
h-rodyklė	83	58
i10-rodyklė	158	114

3000

1500

750

2250

19992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202564 144 290 267 449 373 438 408 540 541 533 651 703 834 878 694 887 878 987 1299 1041 1540 1963 2372 2661 2923 407

Viešas pasiekiamumas

Peržiūrėti viską

55 straipsniai

1 straipsnis

pasiekiami

nepasiekiami

Pagal finansavimo įpareigojimus

Bendraautoriai

Katrin PrellerUniversity of ZurichPatvirtintas el. paštas bli.uzh.ch
Michael KometerUnknown affiliationPatvirtintas el. paštas bli.uzh.ch
Erich SeifritzProfessor of Psychiatry, University of ZürichPatvirtintas el. paštas bli.uzh.ch
Mark A GeyerProfessor of Psychiatry, University of California San DiegoPatvirtintas el. paštas ucsd.edu
André SchmidtUniversity of Basel, Department of Psychiatry (UPK)Patvirtintas el. paštas unibas.ch
Boris B. QuednowProfessor Pharmakopsychologie, Universität ZürichPatvirtintas el. paštas bli.uzh.ch
Erich StuderusLecturer and researcher at the University of Applied Sciences Northwestern SwitzerlandPatvirtintas el. paštas fhnw.ch
Daniel Umbrichtxperimed GmbHPatvirtintas el. paštas xperimed.com
Alan AnticevicCEO @ Manifest Technologies, Former Glenn H. Greenberg Associate Professor, Yale UniversityPatvirtintas el. paštas manifesttech.io
Jie Lisa JiYale UniversityPatvirtintas el. paštas yale.edu
Joram FeldonETH-zPatvirtintas el. paštas behav.biol.ethz.ch
Olivia CarterUniversity of MelbournePatvirtintas el. paštas unimelb.edu.au
Milan ScheideggerPsychiatric University Clinic Zurich and University of ZurichPatvirtintas el. paštas bli.uzh.ch
John KrystalRobert L. McNeil, Jr., Professor of Translational Research, Chair of Psychiatry, Yale UniversityPatvirtintas el. paštas yale.edu
Grega RepovšAssociate Professor of Psychology, University of LjubljanaPatvirtintas el. paštas psy.ff.uni-lj.si
John D. MurrayGregg L. Engles Associate Professor of Psychological and Brain Sciences, Dartmouth CollegePatvirtintas el. paštas dartmouth.edu
Marcus HerdenerUniversity of ZurichPatvirtintas el. paštas bli.uzh.ch
Adeel RaziAssociate Professor, Monash University, AusraliaPatvirtintas el. paštas monash.edu
Guy WallisUniversity of QueenslandPatvirtintas el. paštas uq.edu.au
Flora MoujaesUniversity of ZurichPatvirtintas el. paštas bli.uzh.ch

Stebėti

Franz X. Vollenweider

Professor of Psychiatry, University of Zürich

Patvirtintas el. paštas bli.uzh.ch - Pagrindinis puslapis

Neuropsychopharmacology foundation of consciousness models of psychosis neurobiology of psychedlics hallucinogens


Pavadinimas Rūšiuoti pagal šaltinius Rūšiuoti pagal metus Rūšiuoti pagal pavadinimą	Cituota Cituota	Metai
Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action FX Vollenweider, MFI Vollenweider-Scherpenhuyzen, A Bäbler, H Vogel, ... Neuroreport 9 (17), 3897-3902, 1998	1181	1998
The neurobiology of psychedelic drugs: implications for the treatment of mood disorders FX Vollenweider, M Kometer Nature Reviews Neuroscience 11 (9), 642, 2010	891	2010
Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia D Umbricht, L Schmid, R Koller, FX Vollenweider, D Hell, DC Javitt Archives of general psychiatry 57 (12), 1139-1147, 2000	723	2000
Psychometric evaluation of the altered states of consciousness rating scale (OAV) E Studerus, A Gamma, FX Vollenweider PloS one 5 (8), e12412, 2010	710	2010
Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies E Studerus, M Kometer, F Hasler, FX Vollenweider Journal of psychopharmacology 25 (11), 1434-1452, 2011	624	2011
Psychological and cardiovascular effects and short-term sequelae of MDMA (“ecstasy”) in MDMA-naıve healthy volunteers FX Vollenweider, A Gamma, M Liechti, T Huber Neuropsychopharmacology 19 (4), 241-251, 1998	622	1998
Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose–effect study F Hasler, U Grimberg, MA Benz, T Huber, FX Vollenweider Psychopharmacology 172, 145-156, 2004	574	2004
Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis FX Vollenweider, KL Leenders, C Scharfetter, P Maguire, O Stadelmann, ... Neuropsychopharmacology 16 (5), 357-372, 1997	544	1997
Serotonin research: contributions to understanding psychoses MA Geyer, FX Vollenweider Trends in pharmacological sciences 29 (9), 445-453, 2008	540	2008
Acute effects of lysergic acid diethylamide in healthy subjects Y Schmid, F Enzler, P Gasser, E Grouzmann, KH Preller, FX Vollenweider, ... Biological psychiatry 78 (8), 544-553, 2015	514	2015
Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission … FX Vollenweider, KL Leenders, I Øye, D Hell, J Angst European Neuropsychopharmacology 7 (1), 25-38, 1997	495	1997
Gender differences in the subjective effects of MDMA ME Liechti, A Gamma, FX Vollenweider Psychopharmacology 154, 161-168, 2001	474	2001
Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders FX Vollenweider, KH Preller Nature Reviews Neuroscience 21 (11), 611-624, 2020	463	2020
Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F] fluorodeoxyglucose (FDG) FX Vollenweider, KL Leenders, C Scharfetter, A Antonini, P Maguire, ... European neuropsychopharmacology 7 (1), 9-24, 1997	452	1997
A systems model of altered consciousness: integrating natural and drug-induced psychoses FX Vollenweider, MA Geyer Brain research bulletin 56 (5), 495-507, 2001	450	2001
The fabric of meaning and subjective effects in LSD-induced states depend on serotonin 2A receptor activation KH Preller, M Herdener, T Pokorny, A Planzer, R Kraehenmann, ... Current Biology 27 (3), 451-457, 2017	436	2017
Prediction of psilocybin response in healthy volunteers E Studerus, A Gamma, M Kometer, FX Vollenweider PloS one 7 (2), e30800, 2012	410	2012
5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man—a PET study with [11C] raclopride FX Vollenweider, P Vontobel, D Hell, KL Leenders Neuropsychopharmacology 20 (5), 424-433, 1999	393	1999
Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials, and visual hallucinations M Kometer, A Schmidt, L Jäncke, FX Vollenweider Journal of Neuroscience 33 (25), 10544-10551, 2013	388	2013
Psilocybin-induced decrease in amygdala reactivity correlates with enhanced positive mood in healthy volunteers R Kraehenmann, KH Preller, M Scheidegger, T Pokorny, OG Bosch, ... Biological psychiatry 78 (8), 572-581, 2015	374	2015

Sistema negali atlikti operacijos. Bandykite vėliau dar kartą.

Straipsniai 1–20

Šaltinių per metus

Dubliuoti šaltiniai

Sujungti šaltiniai

Pridėti bendraautoriusBendraautoriai

Stebėti

Cituota

Bendraautoriai